The neurobiology and treatment of first-episode schizophrenia

被引:165
作者
Kahn, R. S. [1 ]
Sommer, I. E. [1 ]
机构
[1] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, NL-3584 CX Utrecht, Netherlands
关键词
MAGNETIC-RESONANCE SPECTROSCOPY; ULTRA-HIGH RISK; DRUG-NAIVE PATIENTS; DOPAMINE SYNTHESIS CAPACITY; C-REACTIVE PROTEIN; DORSOLATERAL PREFRONTAL CORTEX; MATERNAL IMMUNE ACTIVATION; NMDA RECEPTOR HYPOFUNCTION; HIGH-AFFINITY STATE; HIGH GENETIC RISK;
D O I
10.1038/mp.2014.66
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects. Since ICV is driven by brain growth, which reaches its maximum size at approximately 13 years of age, this finding suggests that brain development in patients with schizophrenia is stunted before that age. The smaller brain volume is expressed as decrements in both grey and white matter. After diagnosis, it is mainly the grey matter loss that progresses over time whereas white matter deficits are stable or may even improve over the course of the illness. To understand the possible causes of the brain changes in the first phase of schizophrenia, evidence from treatment studies, postmortem and neuroimaging investigations together with animal experiments needs to be incorporated. These data suggest that the pathophysiology of schizophrenia is multifactorial. Increased striatal dopamine synthesis is already evident before the time of diagnosis, starting during the at-risk mental state, and increases during the onset of frank psychosis. Cognitive impairment and negative symptoms may, in turn, result from other abnormalities, such as NMDA receptor hypofunction and low-grade inflammation of the brain. The latter two dysfunctions probably antedate increased dopamine synthesis by many years, reflecting the much earlier presence of cognitive and social dysfunction. Although correction of the hyperdopaminergic state with antipsychotic agents is generally effective in patients with a first-episode psychosis, the effects of treatments to correct NMDA receptor hypofunction or low-grade inflammation are (so far) rather modest at best. Improved efficacy of these interventions can be expected when they are applied at the onset of cognitive and social dysfunction, rather than at the onset of psychosis.
引用
收藏
页码:84 / 97
页数:14
相关论文
共 224 条
  • [1] Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: A pilot study
    Abdel-Baki, Amal
    Brazzini-Poisson, Veronique
    Marois, Francis
    Letendre, Elaine
    Karelis, Antony D.
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 149 (1-3) : 112 - 115
  • [2] Prefrontal dopamine D1 receptors and working memory in schizophrenia
    Abi-Dargham, A
    Mawlawi, O
    Lombardo, I
    Gil, R
    Martinez, D
    Huang, YY
    Hwang, DR
    Keilp, J
    Kochan, L
    Van Heertum, R
    Gorman, JM
    Laruelle, M
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (09) : 3708 - 3719
  • [3] Increased prefrontal cortical D1 receptors in drug naive patients with schizophrenia: a PET study with [11C]NNC112
    Abi-Dargham, Anissa
    Xu, Xiaoyan
    Thompson, Judy L.
    Gil, Roberto
    Kegeles, Lawrence S.
    Urban, Nina
    Narendran, Raj
    Hwang, Dah-Ren
    Laruelle, Marc
    Slifstein, Mark
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (06) : 794 - 805
  • [4] Is the Acute NMDA Receptor Hypofunction a Valid Model of Schizophrenia?
    Adell, Albert
    Jimenez-Sanchez, Laura
    Lopez-Gil, Xavier
    Romon, Tamara
    [J]. SCHIZOPHRENIA BULLETIN, 2012, 38 (01) : 9 - 14
  • [5] An Algorithm-Based Approach to First-Episode Schizophrenia: Response Rates Over 3 Prospective Antipsychotic Trials With a Retrospective Data Analysis
    Agid, Ofer
    Arenovich, Tamara
    Sajeev, Gautam
    Zipursky, Robert B.
    Kapur, Shitij
    Foussias, George
    Remington, Gary
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1439 - 1444
  • [6] Abnormal Relationship Between Medial Temporal Lobe and Subcortical Dopamine Function in People With an Ultra High Risk for Psychosis
    Allen, Paul
    Chaddock, Christopher A.
    Howes, Oliver D.
    Egerton, Alice
    Seal, Marc L.
    Fusar-Poli, Paolo
    Valli, Isabel
    Day, Fern
    McGuire, Philip K.
    [J]. SCHIZOPHRENIA BULLETIN, 2012, 38 (05) : 1040 - 1049
  • [7] Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial
    Amminger, G. Paul
    Schafer, Miriam R.
    Papageorgiou, Konstantinos
    Klier, Claudia M.
    Cotton, Sue M.
    Harrigan, Susan M.
    Mackinnon, Andrew
    McGorry, Patrick D.
    Berger, Gregor E.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (02) : 146 - 154
  • [8] Relapse Duration, Treatment Intensity, and Brain Tissue Loss in Schizophrenia: A Prospective Longitudinal MRI Study (vol 170, pg 609, 2013)
    Andreasen, Nancy C.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (06) : 689 - 689
  • [9] NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia
    Anticevic, Alan
    Gancsos, Mark
    Murray, John D.
    Repovs, Grega
    Driesen, Naomi R.
    Ennis, Debra J.
    Niciu, Mark J.
    Morgan, Peter T.
    Surti, Toral S.
    Bloch, Michael H.
    Ramani, Ramachandran
    Smith, Mark A.
    Wang, Xiao-Jing
    Krystal, John H.
    Corlett, Philip R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (41) : 16720 - 16725
  • [10] Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia
    Arnold, SE
    Trojanowski, JQ
    Gur, RE
    Blackwell, P
    Han, LY
    Choi, C
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (03) : 225 - 232